Pulled muscles keep athletes out for weeks. A review of nine clinical trials found that a PRP injection made from the patient’s own blood got people back to sport about a week sooner.
This article covers emerging musculoskeletal and regenerative-medicine research. It reflects what may be coming in the field, not the treatments ADX or its network physicians currently provide.
Why it matters
A torn or pulled muscle is one of the most common injuries in sports and in everyday life. Most heal on their own, but slowly, and the time lost matters to anyone who needs to get back to work or play. This study pooled the best trials to date and found that a shot of the patient’s own concentrated platelets sped up healing without adding risk. It is not a cure, but it may be a real, measurable shortcut.
Summary
Acute muscle injuries, most often hamstring strains, account for a large share of time lost in sport. Standard care is rest, progressive loading, and rehabilitation. Platelet-rich plasma (PRP), a concentrate of the patient’s own platelets and growth factors injected into the injured tissue, has been used for years to try to speed muscle healing, but individual trials have been small and their results inconsistent. Systematic reviews a decade ago concluded there was no clear benefit.
In a systematic review and meta-analysis published May 12, 2026 in Sports Medicine – Open, Filardo and colleagues searched PubMed, Cochrane, and Web of Science through January 2026 and pooled every randomized controlled trial comparing PRP injection with rehabilitation alone or placebo for acute muscle injury. Nine trials with 474 patients qualified. The primary outcome was time to return to sport; pain, re-injury, and complication rates were also analyzed. The authors added a fragility analysis, a statistical check of how many patients would need a different result to overturn each finding, which is a useful guard against fragile conclusions in small-trial fields.
PRP shortened time to return to sport by a mean of 7.5 days overall (p < 0.001), with a continuous fragility index of 188, meaning the result was robust. The benefit held in the sub-analysis limited to double-blind trials (8.8 days) and in the hamstring-only sub-analysis (7.5 days). PRP also produced slightly greater pain relief in the hamstring group, though the difference (0.4 points on a 10-point scale) is of limited clinical relevance. Re-injury and complication rates were no different from controls, indicating a safety profile similar to rehabilitation alone.
Caveats are important. Four of the nine trials were rated low risk of bias and five high risk, and the GRADE assessment judged the overall quality of evidence as limited. PRP preparations, injection timing, and rehabilitation protocols varied across trials, which makes it hard to say which version of the treatment works best. A one-week gain in return to sport is meaningful for a competitive athlete and modest for everyone else. What this analysis adds is the strongest pooled evidence so far that PRP for acute muscle tears is safe and offers a real but moderate acceleration of recovery. Larger standardized trials are still needed before it becomes routine.
Source: Filardo et al., Platelet-Rich Plasma Accelerates the Return to Sport in Athletes with Acute Muscle Injuries: A Systematic Review and Statistical Fragility Index-Based Meta-Analysis of Randomized Controlled Trials. Sports Medicine – Open, 2026;12:55 (PubMed). Full text: doi:10.1186/s40798-026-01017-w.
Research compiled by ADX AI Agent, reviewed by Sean Gallivan